Zydus moves Delhi HC against order restraining sale of its cancer drug
on Thursday moved the division bench of the
Delhi High Court
against its single judge's earlier order that temporarily restrained the Ahmedabad-based drug maker from manufacturing, selling
biosimilar
of US pharma giant E.R. Squibb's patent
Nivolumab
, a therapeutic antibody used in the treatment of cancer.
The Division Bench while refusing to stay the single judge's interim order sought response from the US pharma company, which had alleged
patent infringement
of its blockbuster anticancer drug Opdyta (nivolumab) branded as Opdivo in other countries. In India, Nivolumab is being imported and marketed as Opdyta.
Explore courses from Top Institutes in
Please select course:
Select a Course Category
PGDM
Technology
Digital Marketing
Data Science
Others
Management
Cybersecurity
Healthcare
Data Science
Product Management
Public Policy
MBA
others
Design Thinking
Finance
Leadership
Project Management
CXO
MCA
Data Analytics
Artificial Intelligence
Operations Management
healthcare
Degree
Skills you'll gain:
Financial Analysis & Decision Making
Quantitative & Analytical Skills
Organizational Management & Leadership
Innovation & Entrepreneurship
Duration:
24 Months
IMI Delhi
Post Graduate Diploma in Management (Online)
Starts on
Sep 1, 2024
Get Details
While Squibb alleged that Zydus was conducting clinical trials for nivolumab and had plans to launch it during is valid patent period, the Indian company denied the allegations, saying its product ZRC-3276 does not infringe upon the existing patents, was following the regulatory provisions and had applied for a marketing approval with the central drug regulatory agency.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Simoes Filho: Unsold Furniture Liquidation 2024 (Prices May Surprise You)
Unsold Furniture | Search Ads
Learn More
Undo
Zydus argued that its product, ZRC-3276, is bio-similar to Squibb Nivolumab, but bio-similarity by itself does not substantiate infringement as it is based upon product-to-product comparison, whereas, infringement required claim to product mapping.
The generic drug maker claimed that process steps were already known from the prior art and even several techniques for the preparation of human anti-PD1 antibodies were well-known on the priority date of the suit patent.
Live Events
The post-grant opposition that was filed by its subsidiary Zydus Healthcare led to the recommendation for revocation of the suit patent by the Opposition Board, and the said recommendation clearly showed that such a method was commonly employed to produce antibodies, the Ahmedabad-based drug manufacturer claimed.
On July 18, Justice Mini Pushkarna had noted that E.R. Squibb shall suffer irreparable loss in case an interim relief was not granted. Therefore, the single judge had restrained Zydus from selling a biosimilar of Nivolumab till the main suit was decided.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
20 minutes ago
- Time of India
Ansett Australia set for big return decades after collapse, but in never seen before avatar; here's what to expect
Over two decades after the collapse, Ansett Australia, which was once the country's second-largest airline, is all set to return in a new avatar. Ansett Australia collapsed into administration after suffering financial troubles in 2001. Its final flight was recorded early in 2002. More than 16,000 people lost jobs following the company's downfall. Now, two decades later, the brand is scripting a revival in a way Australians wouldn't have ever imagined. It is making a return not as an airline but as an AI-powered holiday booking platform called Ansett Travel , according to 7News. Explore courses from Top Institutes in Please select course: Select a Course Category healthcare Cybersecurity MCA others Product Management Design Thinking PGDM Leadership Public Policy Data Science CXO Operations Management Healthcare MBA Others Management Technology Finance Data Analytics Digital Marketing Degree Data Science Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details How is Ansett Travel designed Speaking about Ansett Travel, Melbourne-based entrepreneur Constantine Frantzeskos said it was designed to be a 'hyper-personalized' travel agent that suggests trips and itineraries based on your preferences, calendar events, and budgets. 'I didn't just acquire a lapsed trademark and domain; I resurrected trust embedded deep in collective memory,' Frantzeskos was quoted by 7News as saying on Monday (July 28, 2025). 'The original Ansett served Australians beautifully for 65 years before collapsing in 2002, leaving a void in reliability and brand warmth. I believe that legacy still matters and that it's deserving of being reimagined for modern travellers. Ansett Travel isn't about replicating the past; it's about re‑engineering it through AI as the core, not as an afterthought,' Frantzeskos continued. Live Events What will Ansett Travel offer Frantzeskos has worked with Emirates, Dubai Tourism, and Visit Victoria in the past. This time, he has partnered with Victorian travel start-up Travlr. He said the new platform is 'like the Costco of travel.' It is open to everyone, 'but if you want the really good stuff,' flights, hotels, and holidays at near-wholesale prices, you will need to join Ansett VIP, he said. Ansett VIP membership An Ansett VIP membership is $99 a year, according to 7News. Not all AI features are live yet, but Frantzeskos said plans for things like auto-generated itineraries, pre-trip alerts, and personalized loyalty experiences are in the works. 'Today's travel platforms are reactive,' he said. 'You search, compare, click. Ansett seeks to flip that model. 'It's designed to anticipate when users need a break, school holidays, anniversaries, executive downtime, or great weather for a weekend away, and offer options before you even think to ask. It's not replacing human agents; it's doing what scale, data, and logic do best—with finesse, not friction.' The website is already live and offering travel deals for destinations including Las Vegas, Bali, Tokyo, and Athens. Before its collapse, Ansett reportedly flew about 10 million passengers annually.
Time of India
21 minutes ago
- Time of India
India's revenue foregone in first year of trade pact with UK estimated at Rs 4,060 cr: GTRI
India is expected to forego customs revenue of Rs 4,060 crore in the first year of the free trade agreement with the UK, as tariffs are reduced or eliminated on a wide range of goods, think tank Global Trade Research Initiative ( GTRI ) said on Monday. The calculation is based on the current import figures from the UK. Explore courses from Top Institutes in Please select course: Select a Course Category MBA Public Policy Operations Management Digital Marketing Product Management Artificial Intelligence Management Data Science CXO Finance healthcare Data Science Design Thinking Project Management Cybersecurity MCA Degree Data Analytics Others Healthcare Leadership PGDM Skills you'll gain: Analytical Skills Financial Literacy Leadership and Management Skills Strategic Thinking Analytical Skills Financial Literacy Leadership and Management Skills Strategic Thinking Duration: 24 Months Vellore Institute of Technology VIT Online MBA Starts on Aug 14, 2024 Get Details Skills you'll gain: Analytical Skills Financial Literacy Leadership and Management Skills Strategic Thinking Duration: 24 Months Vellore Institute of Technology VIT Online MBA Starts on Aug 14, 2024 Get Details Skills you'll gain: Financial Management Team Leadership & Collaboration Financial Reporting & Analysis Advocacy Strategies for Leadership Duration: 18 Months UMass Global Master of Business Administration (MBA) Starts on May 13, 2024 Get Details By the tenth year, it said, as tariff elimination phases-in more broadly, the annual loss is projected to rise to Rs 6,345 crore or around British Pound 574 million, based on FY2025 trade volumes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like If you have a mouse, play this game for 1 minute Navy Quest Undo The India-UK free trade agreement , which was signed on July 24, will lead to a loss of customs revenue for both the countries, as tariffs are reduced or eliminated on a wide range of goods, GTRI added. India imported USD 8.6 billion worth of goods from the UK in 2024-25. Live Events Industrial products make up the bulk of these imports and face a weighted average tariff of 9.2 per cent. Most agricultural products, subject to much higher average tariffs of 64.3 per cent, were excluded from tariff cuts, except for items like whisky and gin. It said that India has committed to eliminating tariffs on 64 per cent of the value of imports from the UK immediately as the implantation starts. Overall, India will eliminate tariffs on 85 per cent of tariff lines and reduce tariff on 5 per cent of tariff lines or product categories. "Based on these factors, India's revenue foregone in the first year of the agreement is estimated at Rs 4,060 crore," GTRI Founder Ajay Srivastava said. He added that the UK imported USD 14.5 billion worth of goods from India in the last fiscal year, with a weighted average import tariff of 3.3 per cent. Under the comprehensive economic and trade agreement (CETA), the UK has agreed to eliminate tariffs on 99 per cent of Indian imports. "This translates to an estimated annual revenue loss of British Pound 375 million (or USD 474 million or Rs 3,884 crore) for the UK, again based on FY2025 trade data. As Indian exports to the UK expand, the fiscal impact is likely to grow over time," it said. The implementation of the pact may take about a year as it requires approval from the UK parliament.
Mint
36 minutes ago
- Mint
Valterra Platinum First-Half Profit Falls on Rain-Hit Output
(Bloomberg) -- Valterra Platinum Ltd. said first-half profit fell 91%, after flooding at a key mine cut production and the company incurred costs during its recent spinoff from Anglo American Plc. The Johannesburg-based miner slashed its interim dividend to 2 rand per share, a drop of 79% from a year earlier, according to results released on Monday. Valterra completed its separation from Anglo at the start of June when it also added a secondary listing in London. While the flooding curbed first-half output at its Amandelbult operation by 45%, Valterra still expects to meet its annual target for refined production of 3 million to 3.4 million ounces of platinum-group metals. The impacted mine is the second largest in the South African company's portfolio, after Mogalakwena. The section of Amandelbult that was most impacted by heavy rains in February resumed operations in June and is expected to reach normal production in the current quarter, Valterra said. The company said production of refined platinum-group metals was down 22% to 1.4 million ounces during the first six months of the year, due to lower availability of concentrates and a stock count that takes place every three years. While Valterra and its peers in South Africa – which is by far the world's largest platinum producer – have been tackling a prolonged slump in PGM prices, there have been recent signs of improvement. Platinum and palladium have risen 56% and 37%, respectively, this year – with most of those increases occurring since the beginning of May. Platinum's gains in the first half of the year 'were underpinned by a more favorable macro-backdrop,' while 'strong Chinese buying, attributed to renewed interest from local jewelry manufacturers and investors, met underwhelming supply given relatively low South African production earlier in the year,' Valterra said. (Updates with information throughout) More stories like this are available on
